TY - JOUR T1 - Perioperative β-blockade improves outcomes in higher risk patients following non-cardiac surgery JF - Evidence Based Medicine JO - Evid Based Med SP - 26 LP - 26 DO - 10.1136/eb-2013-101408 VL - 19 IS - 1 AU - Prashant Vaishnava AU - Kim A Eagle Y1 - 2014/02/01 UR - http://ebm.bmj.com/content/19/1/26.abstract N2 - Commentary on: London MJ, Hur K, Schwartz GG, et al. Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA 2013;309:1704–13.OpenUrlCrossRefPubMedWeb of Science There has been recent controversy in the perioperative community amid allegations of scientific misconduct and there remains uncertainty about the effectiveness and safety of perioperative β-blockade in patients undergoing non-cardiac surgery.1 Current American Heart Association/American College of Cardiology Foundation (AHA/ACCF) Guidelines on perioperative evaluation and care for non-cardiac surgery limit a class I practice recommendation to the continuation of pre-existing β-blockade.2 The authors conducted a retrospective cohort analysis of a population-based sample of 136 745 patients who were 1:1 matched on propensity scores treated at 104 veterans affairs (VA) medical centres (96.3% men in full cohort). Perioperative risk, process and outcome data from patients undergoing non-cardiac surgical procedures … ER -